Breath biomarkers for lung cancer screening
Owlstone Medical develops Breath Biopsy® technology for non-invasive diagnostics and biomarker discovery, focusing on diseases such as cancer, liver disease, respiratory, and cardiometabolic conditions. Their mission is to save lives and reduce healthcare costs by early disease detection through breath analysis.